Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
Antonietta Romano(University of Padua), A. Albertí(University of Padua), Luisa Cavalletto(University of Padua), Franco Noventa(University of Padua), Giada Carolo, Valter Vincenzi, Patrizia Burra(University of Padua), Francesco Paolo Russo(University of Padua), Sara Piovesan, Franco Capra(University of Verona), Pier Giorgio Scotton(University of Milan), M. Carrara, Sandro Panese, Liliana Chemello(University of Padua), Giovanna Scroccaro(Regione del Veneto), Antonio Carlotto, Martina Gambato(University of Padua), Paolo Angeli(University of Padua), Diego Tempesta(Ospedale Civile di Venezia), T. Bertin(Ospedale San Bortolo)
Cited by 166
Related Papers
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
|Journal of Hepatology|2018|2.8k
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k